Upsher-Smith Laboratories

From Wikipedia, the free encyclopedia
Upsher-Smith Laboratories
Company typeSubsidiary of publicly traded company
IndustryPharmaceuticals
Founded1919; 105 years ago (1919) in Wayzata, Minnesota, U.S.
HeadquartersMaple Grove, Minnesota, U.S.
Key people
Productsgeneric drugs, pharmaceutical drugs
ParentSawai Group Holdings Co., Ltd. [jp]
Websitewww.upsher-smith.com

Upsher-Smith Laboratories, LLC is an American pharmaceutical company based in Maple Grove, Minnesota. It was founded in 1919. Upsher-Smith is owned by Japan-based Sawai Group Holdings Co., Ltd. [jp].

Locations[edit]

History[edit]

Founded in 1919 as a maker of digitalis drugs,[4] Upsher-Smith has traditionally focused on the manufacture of generic medications. In 2017, after owning and operating Upsher-Smith for 47 years, the Evenstad family made the decision to sell the largest part of their company, the generics business, to Sawai Group Holdings Co., Ltd. [jp], a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.[5]

Upsher-Smith's non-generic pharmaceuticals businesses, Proximagen, Pairnomix, and MOBĒ, remained with ACOVA, a holding company owned by the Evenstads.

Products[edit]

Upsher-Smith offers brand and generic pharmaceuticals to treat the following disease states:[6]

References[edit]

  1. ^ "Taku Nakaoka Named CEO of Upsher-Smith Laboratories".
  2. ^ "Executive Team".
  3. ^ a b c "Locations – Upsher-Smith". Upsher-Smith Laboratories, LLC. Retrieved 2022-06-21.
  4. ^ "Upsher-Smith History".
  5. ^ "Sawai Pharmaceutical Completes Acquisition of Upsher-Smith Laboratories Generics Business". May 31, 2017.
  6. ^ "Upsher-Smith Products".